Clinical Features of EAE in IL-11Rα<sup>+/+</sup> and IL-11Rα<sup>−/−</sup> mice treated with IVIg or HSA.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Values for day of onset, cumulative score are means (SEM). Values for peak score are shown as median (25 percentile). Between-group peak score was analyzed using a Kruskal Wallis test. The day of onset and cumulative score features were analyzed using a one-way ANOVA and Tukey post-hoc test. A chi-square test was used to analyze whether disease incidence differed between IVIg and HSA counterparts. *indicates a significant difference (p<0.05) from the HSA counterpart. Sample sizes (N) are as indicated.
创建时间：
2014-07-31
